Evidence map›Paper›PMID 40150027›Full record

ArticleDiagnostics (Basel, Switzerland)2025

Characteristics and Neoplastic Progression in Barrett's Esophagus: A Large Population-Based Study from Iceland.

Ken Namikawa, Melkorka Sverrisdottir, Hilmar Freyr Fridgeirsson, Hjalti Dagur Hjaltason, Helgi Kristinn Sigmundsson, Jon Gunnlaugur Jonasson, Einar Stefan Bjornsson, Magnus Konradsson

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ken NamikawaDepartment of Gastroenterology, Landspitali-The National University Hospital of Iceland, 101 Reykjavik, Iceland.
Melkorka SverrisdottirFaculty of Medicine, University of Iceland, 101 Reykjavik, Iceland.
Hilmar Freyr FridgeirssonFaculty of Medicine, University of Iceland, 101 Reykjavik, Iceland.
Hjalti Dagur HjaltasonFaculty of Medicine, University of Iceland, 101 Reykjavik, Iceland.
Helgi Kristinn SigmundssonFaculty of Medicine, University of Iceland, 101 Reykjavik, Iceland.
Jon Gunnlaugur JonassonFaculty of Medicine, University of Iceland, 101 Reykjavik, Iceland.
Einar Stefan BjornssonDepartment of Gastroenterology, Landspitali-The National University Hospital of Iceland, 101 Reykjavik, Iceland.ORCID 0000-0002-8392-0632
Magnus KonradssonDepartment of Gastroenterology, Landspitali-The National University Hospital of Iceland, 101 Reykjavik, Iceland.

Funding

National University Hospital of Iceland A-2024-35
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Barrett’s esophagusdysplasiaepidemiologyesophageal adenocarcinomaIcelandprogression

Identifiers

PMID40150027
PMCPMC11941158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.